blank blank blank blank
blank blank Orin Group Logo blank blank blank
  Orin Grou Logo Orin Group Logo Orin Group Logo Orin Group Logo  
Orin Group Navigation Orin Group Navigation  

The Orin Group, LLC News  
 
Oringen, LLC a subsidiary of The Orin Group, LLC wishes to present the following press release: 
 
Kent, OH Oringen LLC of Tallmadge, Ohio, announces that it has licensed shared proprietary technology for the creation of liquid crystal biosensors from Kent State University, Kent, Ohio and the Northeastern Ohio Universities College of Medicine (NEOUCOM), Rootstown, Ohio. The patented technology is a revolutionary approach to detect microorganisms in real time. Oringen is developing the technology for homeland security, military and medical applications. Oringen CEO, John O. Krusinski, said that he is excited about the opportunities presented by this agreement. Krusinski is planning to extend the research and development of the liquid crystal sensor technology with prototyping and initial manufacturing in Portage County, Ohio. Product development is anticipated to begin within the next 9 months with sales expected within 2 years. 
 
Initially conceived by scientists at Kent State University and co-developed with scientists at NEOUCOM, the liquid crystal sensor technology has been used in the laboratory to detect surrogates (imposters) of anthrax and smallpox, demonstrating its potential use against agents of bioterrorism. Additionally, it has been successfully used to detect common human pathogens such as Staphylococcus aureus and E. coli. This platform technology shortens the time to results from hours or days to minutes. "It is faster, less expensive and potentially more sensitive than anything on the market today", said Krusinski. As a point of care device, this sensor will enable physicians to diagnose infectious disease within minutes, allowing more immediate and effective treatments. 
 

Inventors Chris Woolverton, KSU associate professor of Biological Sciences, Oleg Lavrentovich, KSU professor of the Chemical Physics Interdisciplinary Program, and Gary Niehaus, NEOUCOM associate professor of Physiology and Pharmacology will be working with Oringen to continue research and advise on product development. Woolverton, Lavrentovich and Niehaus have presented the technology at international conferences and have been recognized by Scientific American and New Scientist magazines for their efforts. The team has twice been nominated for the Northern Ohio Live Award in Achievement (Health and Medicine Division) for their technology. Woolverton has twice been recognized by Crain's Cleveland Business Who's Who in Technology. 

Back to current news item.

 

 

   
blank blank blank blank
blank blank blank blank